Loading...
Loading...
India's cefuroxime imports from ITALY total $797.7M across 36 shipments from 1 foreign suppliers. GLAXOSMITHKLINE EXPORT LIMITED leads with $797.7M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for cefuroxime — a concentrated sourcing relationship with select suppliers from ITALY.

GLAXOSMITHKLINE EXPORT LIMITED is the leading Cefuroxime supplier from ITALY to India, with import value of $797.7M across 36 shipments. The top 5 suppliers — GLAXOSMITHKLINE EXPORT LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE EXPORT LIMITED | $797.7M | 36 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | $797.7M | 36 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cefuroxime suppliers from ITALY to India include GLAXOSMITHKLINE EXPORT LIMITED. The leading supplier is GLAXOSMITHKLINE EXPORT LIMITED with import value of $797.7M USD across 36 shipments. India imported Cefuroxime worth $797.7M USD from ITALY in total across 36 shipments.
India imported Cefuroxime worth $797.7M USD from ITALY across 36 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cefuroxime sourced from ITALY include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. The largest buyer is GLAXOSMITHKLINE PHARMACEUTICALS LIMITED with $797.7M in imports across 36 shipments.
The total value of Cefuroxime imports from ITALY to India is $797.7M USD, across 36 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
36 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists